Evaluating pharmacokinetics of aldometanib in mice
Ended Purchase Order Awarded Last action
- Contract number
- 75N95023P00560
- Awardee
-
Chemogenics Biopharma, LLC UEI MQLWQEJKQLR3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,540
Award facts
- Opportunity
-
- Evaluating pharmacokinetics of aldometanib Special Notice · 75N95023Q00571 · Posted Jul 31, 2023
- Contract value 100% obligated
- $23,540.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27707, USA
Award details come from SAM.gov/FPDS.
About this award
Chemogenics Biopharma, LLC has been awarded a $23,540 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to evaluate the pharmacokinetics of aldometanib in mice. Under the non-competitive contract, Chemogenics will determine aldometanib concentrations in various tissues through synthesis of the compound following a multistep sequence and analytical methods to analyze aldometanib levels. The company will also report and document the results of the evaluation. The place of performance is Durham, North Carolina and the period of performance is from September 21, 2023 through December 20, 2023. The solicitation sought these products and services to advance the National Center's work in translational sciences.
Quick answers
Who was awarded contract 75N95023P00560?
75N95023P00560 was awarded to Chemogenics Biopharma, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 21, 2023.
How much is contract 75N95023P00560 worth?
The government has obligated $23,540 on 75N95023P00560.
Which agency awarded contract 75N95023P00560?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023P00560, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95023P00560 competed?
The extent of competition for 75N95023P00560 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award